|
WO2021016606A1
|
|
Chimeric antigen receptor t cells and uses thereof
|
|
WO2021016609A1
|
|
Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereof
|
|
CA3103936A1
|
|
Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
|
|
AU2019245285A1
|
|
Constructs targeting CD22 and uses thereof
|
|
WO2019183375A1
|
|
Antibody agents specifically recognizing monocarboxylate transporter 4 and uses thereof
|
|
WO2019032699A1
|
|
Cells expressing cell surface receptors and antibodies
|
|
AU2018258049A1
|
|
Constructs specifically recognizing glypican 3 and uses thereof
|
|
WO2018200583A1
|
|
Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof
|
|
TW201831517A
|
|
Constructs targeting histone h3 peptide/mhc complexes and uses thereof
|
|
WO2018057967A2
|
|
Constructs targeting hiv peptide/mhc complexes and uses thereof
|
|
SG10201913247XA
|
|
Antibody/t-cell receptor chimeric constructs and uses thereof
|
|
SG11201803054UA
|
|
Antibody agents specific for human cd19 and uses thereof
|
|
AU2016297259A1
|
|
Constructs targeting PSA peptide/MHC complexes and uses thereof
|
|
US2019382504A1
|
|
Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
|
|
AU2016261356A1
|
|
Constructs targeting HPV16-E7 peptide/MHC complexes and uses thereof
|
|
WO2016161390A1
|
|
Constructs targeting afp peptide/mhc complexes and uses thereof
|
|
US2018127503A1
|
|
Anti-ROR2 Antibodies
|
|
AU2015357526A1
|
|
Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof
|
|
AU2015357543A1
|
|
Chimeric antigen receptors targeting Fc Receptor-like 5 and uses thereof
|
|
AU2015357533A1
|
|
Antibodies targeting B-cell maturation antigen and methods of use
|
